Imago Biosciences Inc (IMGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,915 | -7,109 | -17,833 | -12,283 | -7,975 |
| Depreciation Amortization | 96 | 50 | 7 | -4 | -3 |
| Accounts payable and accrued liabilities | 585 | 1,389 | 8 | -335 | 823 |
| Other Working Capital | 819 | -314 | 672 | 122 | 701 |
| Other Operating Activity | 168 | -1,070 | 204 | 410 | -855 |
| Operating Cash Flow | $-14,247 | $-7,054 | $-16,942 | $-12,090 | $-7,309 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -9 | -4 | -3 |
| Purchase Of Investment | -33,701 | -14,728 | -81,083 | -13,018 | N/A |
| Sale Of Investment | 36,177 | 11,500 | 6,750 | 2,750 | 2,750 |
| Investing Cash Flow | $2,476 | $-3,228 | $-74,342 | $-10,272 | $2,747 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 107 | 0 | 29 | N/A | N/A |
| Other Financing Activity | -1,009 | 0 | 105,560 | 25,858 | 5,967 |
| Financing Cash Flow | $-902 | $N/A | $105,589 | $25,858 | $5,967 |
| Beginning Cash Position | 19,266 | 19,266 | 4,961 | 4,961 | 4,961 |
| End Cash Position | 6,593 | 8,984 | 19,266 | 8,457 | 6,366 |
| Net Cash Flow | $-12,673 | $-10,282 | $14,305 | $3,496 | $1,405 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,247 | -7,054 | -16,942 | -12,090 | -7,309 |
| Capital Expenditure | N/A | N/A | -9 | -4 | -3 |
| Free Cash Flow | -14,247 | -7,054 | -16,951 | -12,094 | -7,312 |